Next Article in Journal
Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
Next Article in Special Issue
Basis of PD1/PD-L1 Therapies
Previous Article in Journal
2017 ACC/AHA Blood Pressure Classification and Cardiovascular Disease in 15 Million Adults of Age 20–94 Years
Previous Article in Special Issue
Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook
 
 
Article

Article Versions Notes

J. Clin. Med. 2019, 8(11), 1833; https://doi.org/10.3390/jcm8111833
Action Date Notes Link
article xml file uploaded 1 November 2019 15:37 CET Original file -
article pdf uploaded. 1 November 2019 15:37 CET Version of Record https://www.mdpi.com/2077-0383/8/11/1833/pdf-vor
article supplementary file uploaded. 1 November 2019 15:37 CET - https://www.mdpi.com/2077-0383/8/11/1833#supplementary
article xml file uploaded 19 November 2019 10:03 CET Update -
article xml uploaded. 19 November 2019 10:03 CET Update https://www.mdpi.com/2077-0383/8/11/1833/xml
article pdf uploaded. 19 November 2019 10:03 CET Updated version of record https://www.mdpi.com/2077-0383/8/11/1833/pdf
article supplementary file uploaded. 19 November 2019 10:03 CET - https://www.mdpi.com/2077-0383/8/11/1833#supplementary
article html file updated 19 November 2019 10:04 CET Original file -
article html file updated 27 November 2019 12:33 CET Update -
article html file updated 29 November 2019 13:17 CET Update -
article html file updated 14 February 2020 06:06 CET Update -
article html file updated 20 July 2022 00:26 CEST Update https://www.mdpi.com/2077-0383/8/11/1833/html
Back to TopTop